Clinical Trial Update: Acotiamide vs Itopride in Postprandial Distress Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing acotiamide with itopride for postprandial distress syndrome is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia
• Postprandial Distress Syndrome

Drugs mentioned

• acotiamide (acotiamide)
• itopride (itopride)

Snippet

Sponsor: Getz Pharma | Conditions: Postprandial Distress Syndrome | Phase 3 | Status: NOT_YET_RECRUITING